PPT-Opioid harm reduction ‘guide’

Improvement ideas for GP practices PCNs About this guide Guide produced as a framework for activity to support work to help people live well with pain for individuals and practices Produced in collaboration with primary care clinicians and allied health professional input with patient input for tips and tricks. Drug policy special session . AIDS 2014 . Melbourne 1300-1400 22 July. Dr. Alex Wodak AM. a. lex.wodak@gmail.com. 1. Basis current global drug policy?. Three international drug treaties. Multiple UN agencies. Dr Nicholas Thomson. Nossal Institute for Global Health. 6th HAARP Consultation and Coordination Forum, Siem Reap, April 2012. What does this mean in the context of harm reduction?. How do we actually do it?. Welcome. Thank you for joining us for our 1. st. AIM Opioid Webinar. Housekeeping:. Session is being recorded. Session will be posted under the opioid section of the AIM website: . https://safehealthcareforeverywoman.org/national-collaborative-on-maternal-oud/. November 17, 2012. Harm Reduction Coalition National Conference. Erin Antunez, SFDPH. Overview. What is San Francisco’s LINCS Program? . How LINCS works with HIV patients and their partners in SFDPH. XTC harm reduction strategies @ Netherlands dr. Peggy van der Pol Drug Monitoring & Policy 2 I have no conflict of interest to declare 3 Nightlife websurvey Min 1x party / festival /club /disco Kentucky Opioid Response Effort: State Targeted Response (STR) State Opioid Response (SOR ) Shelly Steiner Prevention Implementation Specialist April 9, 2019 Kentucky Harm Reduction Summit Statement of Purpose Harm Reduction at the Crossroads Drugs, drug policy, harm reduction: A reality check International AIDS Conference July 25, 2018 Amsterdam Daniel Wolfe Director, International Harm Reduction Development Matt Tice Oksana Kaczmarczyk. . MSW, LCSW. University of Buffalo. Matt . Tice has worked his way through the ranks of Pathways to Housing PA, first as an Assistant Team Leader in 2012, then as a Team Leader, and then as Clinical Director in 2014. . Sara Rainer, program manager. January 22, 2019. 1. Welcome & Introductions. Introduce yourself: . Name. and . Organization. 2. Agenda. CPAA Updates and Announcements. Partner Updates, News, and Opportunities. Joshua Blum MD. April 7, 2018. No relevant financial disclosures. Learning objectives. Utilize the latest evidence around opioid-induced hyperalgesia to mitigate negative consequences . Implement best practices around opioid rotation to manage OIH. Community Placement of Lifesaving Equipment. Naloxone. Overdose antidote. Administered via injection or nasal aerosol. Onset of action 3-15 . mins. Duration of action: 30-45 . mins. Image courtesy of Prescribe to Prevent. BY. IYAMU CLEMENT OSASERE.. FNPH, USELU.. 15. TH. FEBRUARY, 2023.. OUTLINE. Objectives. Introduction. Definition. Harm reduction strategies, goals and principles. Current harm reduction practices. Clinicians role in harm reduction. September 26, 2023. Board Recommendations. OASAS Dollars Made Available. Priority Area. *. FY 23 Allocations. **. Made Available via Procurement. Regional Abatement. $64,006. $64,006. Harm Reduction. In Head and Neck Endocrine Surgery: . An American Head and Neck Society . Endocrine Surgery Section Consensus Statement. JK Ferrell, ML Shindo, BC Stack, Jr., P Angelos, G Bloom, AY Chen, L Davies, JC Irish, T Kroeker, SD McCammon, .